{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:27:15Z","timestamp":1781828835320,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,20]]},"DOI":"10.7759\/cureus.52646","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T07:38:02Z","timestamp":1705822682000},"source":"Crossref","is-referenced-by-count":6,"title":["Epidemiological Perspectives: A Four-Year Insight Into Hepatitis C Surveillance in the Kingdom of Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Ali","family":"Almajid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Albarbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bazroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashim","family":"Al-Awami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahaf","family":"Aljurayyad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"Albadran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Alkhamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider","family":"Alomair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamama","family":"Aljishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v10.i2.186","article-title":"Hepatitis C virus: morphogenesis, infection and therapy","volume":"10","author":"Morozov VA","year":"2018","unstructured":"Morozov VA, Lagaye S. Hepatitis C virus: morphogenesis, infection and therapy. World J Hepatol. 2018, 10:186-212. 10.4254\/wjh.v10.i2.186","journal-title":"World J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults-United States","volume":"69","author":"Schillie S","year":"2020","unstructured":"Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC recommendations for hepatitis C screening among adults-United States. MMWR Recomm Rep. 2020, 69:1-17. 10.15585\/mmwr.rr6902a1","journal-title":"MMWR Recomm Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.11.015","article-title":"The prevalence and correlates of hepatitis C virus (HCV) infection and HCV-HIV co-infection in a community sample of gay and bisexual men","volume":"13","author":"Myers T","year":"2009","unstructured":"Myers T, Allman D, Xu K, et al.. The prevalence and correlates of hepatitis C virus (HCV) infection and HCV-HIV co-infection in a community sample of gay and bisexual men. Int J Infect Dis. 2009, 13:730-9. 10.1016\/j.ijid.2008.11.015","journal-title":"Int J Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.07.015","article-title":"Hepatitis C virus treatment: is it possible to cure all hepatitis C virus patients?","volume":"13","author":"Muir AJ","year":"2015","unstructured":"Muir AJ, Naggie S. Hepatitis C virus treatment: is it possible to cure all hepatitis C virus patients?. Clin Gastroenterol Hepatol. 2015, 13:2166-72. 10.1016\/j.cgh.2015.07.015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","unstructured":"WHO. Hepatitis C Fact Sheet No 164. (2014). Accessed. January 19, 2024: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61116-2","article-title":"Acute hepatitis C","volume":"372","author":"Maheshwari A","year":"2008","unstructured":"Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C. Lancet. 2008, 372:321-32. 10.1016\/S0140-6736(08)61116-2","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1123","article-title":"Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force Recommendation Statement","volume":"323","author":"Owens DK","year":"2020","unstructured":"Owens DK, Davidson KW, Krist AH, et al.. Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020, 323:970-5. 10.1001\/jama.2020.1123","journal-title":"JAMA"},{"key":"ref8","unstructured":"Hepatitis C cases in KSA. (2024). Accessed. January 19, 2024: https:\/\/od.data.gov.sa\/Data\/en\/dataset\/hepatitis-c-cases-in-ksa."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2007.191","article-title":"Hepatitis C virus infections reported in Saudi Arabia over 11 years of surveillance","volume":"27","author":"Madani TA","year":"2007","unstructured":"Madani TA. Hepatitis C virus infections reported in Saudi Arabia over 11 years of surveillance. Ann Saudi Med. 2007, 27:191-4. 10.5144\/0256-4947.2007.191","journal-title":"Ann Saudi Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.34294143941.x","article-title":"Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia","volume":"34","author":"Abdelaal M","year":"1994","unstructured":"Abdelaal M, Rowbottom D, Zawawi T, Scott T, Gilpin C. Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia. Transfusion. 1994, 34:135-7. 10.1046\/j.1537-2995.1994.34294143941.x","journal-title":"Transfusion"},{"key":"ref11","article-title":"Hepatitis C virus seroprevalence rate among Saudis","volume":"24 Suppl 2","author":"Shobokshi OA","year":"2003","unstructured":"Shobokshi OA, Serebour FE, Al-Drees AZ, Mitwalli AH, Qahtani A, Skakni LI. Hepatitis C virus seroprevalence rate among Saudis. Saudi Med J. 2003, 24 Suppl 2:S81-6.","journal-title":"Saudi Med J"},{"key":"ref12","article-title":"Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I\/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia","volume":"25","author":"El-Hazmi MM","year":"2004","unstructured":"El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I\/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J. 2004, 25:26-33.","journal-title":"Saudi Med J"},{"key":"ref13","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965","volume":"61","author":"Smith BD","year":"2012","unstructured":"Smith BD, Morgan RL, Beckett GA, et al.. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012, 61:1-32.","journal-title":"MMWR Recomm Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018","volume":"69","year":"2018","unstructured":"EASL recommendations on treatment of hepatitis C 2018. J Hepatol. 2018, 69.461-511. 10.1016\/j.jhep.2018.03.026","journal-title":"J Hepatol"},{"key":"ref15","article-title":"Hepatitis C genotypes\/subtypes among chronic hepatitis patients in Saudi Arabia","volume":"24 Suppl 2","author":"Shobokshi OA","year":"2003","unstructured":"Shobokshi OA, Serebour FE, Skakni LI. Hepatitis C genotypes\/subtypes among chronic hepatitis patients in Saudi Arabia. Saudi Med J. 2003, 24 Suppl 2:S87-91.","journal-title":"Saudi Med J"},{"key":"ref16","article-title":"Prevalence of selected blood-borne infectious diseases among voluntary blood donors in abha, Saudi Arabia","volume":"52","author":"Alshahrani MY","year":"2021","unstructured":"Alshahrani MY, Alamri AM, Alshahrani AS, et al.. Prevalence of selected blood-borne infectious diseases among voluntary blood donors in abha, Saudi Arabia. Southeast Asian J Trop Med Public Health. 2021, 52:1-10.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2009.03.027","article-title":"Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia","volume":"14","author":"Memish ZA","year":"2010","unstructured":"Memish ZA, Knawy BA, El-Saed A. Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia. Int J Infect Dis. 2010, 14:e115-20. 10.1016\/j.ijid.2009.03.027","journal-title":"Int J Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1993.49.440","article-title":"Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors","volume":"49","author":"Darwish MA","year":"1993","unstructured":"Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg. 1993, 49:440-7. 10.4269\/ajtmh.1993.49.440","journal-title":"Am J Trop Med Hyg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1996.54.554","article-title":"High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study","volume":"54","author":"Darwish MA","year":"1996","unstructured":"Darwish MA, Faris R, Clemens JD, Rao MR, Edelman R. High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study. Am J Trop Med Hyg. 1996, 54:554-8. 10.4269\/ajtmh.1996.54.554","journal-title":"Am J Trop Med Hyg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(99)06527-7","article-title":"The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt","volume":"355","author":"Frank C","year":"2000","unstructured":"Frank C, Mohamed MK, Strickland GT, et al.. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000, 355:887-91. 10.1016\/s0140-6736(99)06527-7","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-2-29","article-title":"Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt","volume":"2","author":"Rao MR","year":"2002","unstructured":"Rao MR, Naficy AB, Darwish MA, Darwish NM, Schisterman E, Clemens JD, Edelman R. Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infect Dis. 2002, 2:29. 10.1186\/1471-2334-2-29","journal-title":"BMC Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2001.64.147","article-title":"Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study","volume":"64","author":"Darwish MA","year":"2001","unstructured":"Darwish MA, Faris R, Darwish N, et al.. Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study. Am J Trop Med Hyg. 2001, 64:147-53. 10.4269\/ajtmh.2001.64.147","journal-title":"Am J Trop Med Hyg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v40i19a01","article-title":"Hepatitis C surveillance in Canada","volume":"40","author":"Payne E","year":"2014","unstructured":"Payne E, Totten S, Archibald C. Hepatitis C surveillance in Canada. Can Commun Dis Rep. 2014, 40:421-8. 10.14745\/ccdr.v40i19a01","journal-title":"Can Commun Dis Rep"},{"key":"ref24","unstructured":"Section 4. Modelling the Incidence and Prevalence of Hepatitis C Infection and its Sequelae in Canada, 2007 - Discussion. (2009). Accessed: January 19, 2024: https:\/\/www.canada.ca\/en\/public-health\/services\/infectious-diseases\/surveillance-epidemiology-sexually-transmitted-in...."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.103425","article-title":"Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?","volume":"18","author":"Abdo AA","year":"2012","unstructured":"Abdo AA, Sanai FM, Al-Faleh FZ. Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?. Saudi J Gastroenterol. 2012, 18:349-57. 10.4103\/1319-3767.103425","journal-title":"Saudi J Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2019.06.001","article-title":"National screening programs in Saudi Arabia: overview, outcomes, and effectiveness","volume":"12","author":"Gosadi IM","year":"2019","unstructured":"Gosadi IM. National screening programs in Saudi Arabia: overview, outcomes, and effectiveness. J Infect Public Health. 2019, 12:608-14. 10.1016\/j.jiph.2019.06.001","journal-title":"J Infect Public Health"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/jpbs.jpbs_166_21","article-title":"Impact of drug use policy on the appropriate use of direct acting antiviral agents for Hepatitis C in Saudi Arabia","volume":"13","author":"Alotaibi AS","year":"2021","unstructured":"Alotaibi AS, Shamas N, Ansari UU, Sanai FM, Alshahrani A, Fathelrahman AI, Aseeri MA. Impact of drug use policy on the appropriate use of direct acting antiviral agents for Hepatitis C in Saudi Arabia. J Pharm Bioallied Sci. 2021, 13:317-24. 10.4103\/jpbs.jpbs_166_21","journal-title":"J Pharm Bioallied Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32237","article-title":"Favorable impact in hepatitis C-related mortality following free access to direct-acting antivirals in Spain","volume":"75","author":"Politi J","year":"2022","unstructured":"Politi J, Guerras JM, Donat M, Belza MJ, Ronda E, Barrio G, Regidor E. Favorable impact in hepatitis C-related mortality following free access to direct-acting antivirals in Spain. Hepatology. 2022, 75:1247-56. 10.1002\/hep.32237","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2018.8.22467","article-title":"Can hepatitis C virus be eliminated by 2030? Saudi Arabia as an example","volume":"39","author":"Altraif I","year":"2018","unstructured":"Altraif I. Can hepatitis C virus be eliminated by 2030? Saudi Arabia as an example. Saudi Med J. 2018, 39:842-5. 10.15537\/smj.2018.8.22467","journal-title":"Saudi Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/223231-epidemiological-perspectives-a-four-year-insight-into-hepatitis-c-surveillance-in-the-kingdom-of-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:12Z","timestamp":1707509532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/223231-epidemiological-perspectives-a-four-year-insight-into-hepatitis-c-surveillance-in-the-kingdom-of-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,20]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.52646","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,20]]}}}